Pramod Sharma

• Managed Country operations , lead three business units as SBUs
• Conceptualized, initiated and formed OTC business unit, aimed at contributing 20% contribution in first year.
• Improved performance outcomes of Hospitals business unit and govt tender business.
• Inducted and trained 28 team members , for various functions and levels.
• 38% overall growth from July 23 base.

• Headed 2 business units - specialty and general - 112 team strength, 6 Mio Usd annual business turnover
• In charge of all functions including - sales and marketing, HRD, Regulatory, supply chain and logistics.
• Acheived over 11% YoY growth
• New divisions/products line up launched contributed 10% to overall revenue.
• Increased team strength - from 80 to 110, improved country coverage and customer reach.

• Headed sales and marketing functions - reported to MD.
• Team of 87 reported to me, including 4 expats and 83 locals.
• Doubled the business revenue from the 2018 base.
• Lunched 3 new products in Gynae range.
• Training and development of sales team at all levels.
• Added tender business and govt hospital supply business units.

Headed North Cluster - based at Delhi

Started North operations, from Delhi, then subsequently added Gurgaon, Jaipur and lucknow units

Improved retail coverage by 39% from previous base.

9 cr monthly revenue achieved

Added 6 new principles during my tenure.

Was responsible for training and development of all workers , from starting level to GM.

• Was in charge of North region and East region - India. Based at Delhi and parallel office at Kolkata.
• Team strength - 154 , monthly revenues - 19 Cr
• Launched Gaviscon brand in India and made it 59 Cr brand in the first year of launch - 2014 - 2015
• Managed the pharmacy channel for RB - headed detailing and retail team.

• Headed country operations - Myanmar
• Team strength - 58
• Annual revenues - 3 Mio Usd
• Major brands - Glycodin, Brozeet, Azithral , Roxid

• Headed division 1 for Ranbaxy Myanmar
• Team strength - 102
• Annual revenues - 6.5 Mio USD
• Major brands - Volini, Caverta, Cifran, Norbactin, Ranferon
• Improved revenues performance from a base of under 3 Mio USD to over 6 Mio USD.
• Turnaround performance for degrowing brands - Caverta and Cifran.
• Handed both Rx & OTC channels.
• Launched Volini - became the No 1 prescribed brand in 2011, one year post launch.

Handled training for 3 BUs

was Incharge for training at all levels - Induction, Post Induction, Managerial, Development centre operations.

Training Manager for Grow division.

In charge for Inductions and post Induction training

Introduced Interventional training, regional training manager concept in organization.

Started as TBM - speciality division, based at South Delhi - AIIMS belt.

Got 5 promotions in next 6 years in organization.